Variant report
Variant | nsv526165 |
---|---|
Chromosome Location | chr5:117730127-117763178 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:117739269..117741179-chr5:117744231..117746382,2 | MCF-7 | breast: | |
2 | chr5:117739269..117741179-chr5:117744231..117746382,2 | MCF-7 | breast: | |
3 | chr5:117747668..117749268-chr5:117752112..117754605,2 | K562 | blood: | |
4 | chr5:117747668..117749268-chr5:117752112..117754605,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531758867 | chr5:117734813-117734814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551470169 | chr5:117734824-117734825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548836641 | chr5:117734832-117734833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142081964 | chr5:117734841-117734842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534050470 | chr5:117734843-117734844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547442428 | chr5:117734845-117734846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567532693 | chr5:117734853-117734854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs12520153 | chr5:117734859-117734860 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs184653679 | chr5:117734861-117734862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535592543 | chr5:117734971-117734972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs60133997 | chr5:117734973-117734974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs576643724 | chr5:117735013-117735014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190383867 | chr5:117735056-117735057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146332629 | chr5:117735080-117735081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556360133 | chr5:117735083-117735084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571958087 | chr5:117735089-117735090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182419393 | chr5:117735122-117735123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559099297 | chr5:117735125-117735126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560954980 | chr5:117735137-117735138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs61662516 | chr5:117735185-117735186 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs139574662 | chr5:117735218-117735219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563635040 | chr5:117735232-117735233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532321119 | chr5:117735250-117735251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546050958 | chr5:117735261-117735262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs557399483 | chr5:117735269-117735270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565139329 | chr5:117735294-117735295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs527641422 | chr5:117735299-117735300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141845776 | chr5:117735320-117735321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547529197 | chr5:117735365-117735366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567420822 | chr5:117735394-117735395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569006706 | chr5:117735601-117735602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs537975855 | chr5:117735604-117735605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140007498 | chr5:117735605-117735606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557714435 | chr5:117735616-117735617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs559591181 | chr5:117735660-117735661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527728463 | chr5:117735694-117735695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs552874278 | chr5:117735701-117735702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541007800 | chr5:117735709-117735710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560910672 | chr5:117735719-117735720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs72791697 | chr5:117735729-117735730 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs80144360 | chr5:117735755-117735756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570161223 | chr5:117735757-117735758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140070632 | chr5:117735767-117735768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35967204 | chr5:117735785-117735786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs78697906 | chr5:117735832-117735833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543628630 | chr5:117735834-117735835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554620630 | chr5:117735879-117735880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568034530 | chr5:117735885-117735886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373912090 | chr5:117735901-117735902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556977880 | chr5:117735942-117735943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22543975 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:117734800-117735400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr5:117735600-117735800 | Enhancers | Right Atrium | heart |
3 | chr5:117735800-117743800 | Weak transcription | Right Atrium | heart |
4 | chr5:117740800-117742000 | Enhancers | Fetal Muscle Trunk | muscle |
5 | chr5:117741000-117742000 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr5:117741200-117741600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr5:117741200-117741800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr5:117741200-117741800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr5:117741400-117741600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr5:117741400-117741600 | Enhancers | Right Ventricle | heart |
11 | chr5:117741400-117741800 | Enhancers | Fetal Stomach | stomach |
12 | chr5:117741400-117742000 | Enhancers | Left Ventricle | heart |
13 | chr5:117741600-117744800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr5:117743400-117744000 | Enhancers | Right Ventricle | heart |
15 | chr5:117743800-117744200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr5:117743800-117744600 | Enhancers | Right Atrium | heart |
17 | chr5:117744000-117744600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |